Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2017 / Articles / Feb / Pharmtastic Voyage
Discovery & Development Drug Delivery

Pharmtastic Voyage

Scientists develop a microscopic “submarine” that neutralizes gastricacid for fuel to safely deliver drugs to the stomach

By James Strachan 02/22/2017 1 min read

Share

In the 1960’s science fiction movie, Fantastic Voyage, Dr Jan Benes is left comatose with a life-threatening blood clot after a Soviet assassination attempt. Captain Bill Owens and his crew have only 60 minutes to board a miniaturized submarine and make their way to the clot, operate, and exit the body before they are returned to normal size, killing the unfortunate Benes. Since its 1966 release, Fantastic Voyage has been widely celebrated, satirized, and now – with a new device developed by Jinxing Li and his team from the Department of Nanoengineering, University of California San Diego – imitated. Although there’s no “atomic miniaturization” involved, Li’s team have developed a microscopic “submarine” that can speed through the stomach using gastric acid for fuel (while simultaneously neutralizing it) and release cargo precisely at the desired pH. The “submarine” is actually a proton-driven, biocompatible micromotor with a pH-dependent polymer coating that can be loaded with drugs.

“Fantastic Voyage features a microscopic submarine that travels inside the human body to treat life-threatening issues,” says Li. “We’re aiming to apply our micro/nanomachines to drug delivery, detoxification and precision surgery.” A number of pH-sensitive compounds are vulnerable to gastric acid – including protein-based drugs and some antibiotics. An enteric coating can usually do the job of preventing degradation in the stomach, but for drugs that need to be activated in the stomach, for instance to treat stomach ulcers, proton pump inhibitors are usually needed to block gastric acid production. When used over longer periods, these can cause some side effects, including headaches, diarrhea, fatigue and, in some severe cases, rhabdomyolysis, a potentially life-threatening muscle disease. Li’s micromotors are microscopic spheres consisting of a magnesium core, which reacts with gastric acid to generate bubbles for propulsion. This process also neutralizes the stomach pH spontaneously (1). “Such motor-induced neutralization of the stomach fluid further triggers the autonomous payload release from the pH-sensitive polymer coating,” says Li.

Where proton pump inhibitors suppress acid in the stomach, the micromotors alter the local environment without blocking the function of the proton pumps. “This approach hardly interferes with the function of the stomach and therefore completely eliminates the side effects associated with proton pump inhibitors,” says Li.  Li hopes that the technology will help improve treatment efficiency since the propulsion of the micromotor allows it to penetrate the gastric mucosa, which increases the amount of time that the drug is retained in the stomach. The journey continues as Li’s team turn their attention to loading real therapeutic agents to treat stomach infections.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. J Li et al., “Micromotors Spontaneously Neutralize Gastric Acid for pH-Responsive Payload Release”, Angewandte Chemie International Edition, (2017).

About the Author(s)

James Strachan

Over the course of my Biomedical Sciences degree it dawned on me that my goal of becoming a scientist didn’t quite mesh with my lack of affinity for lab work. Thinking on my decision to pursue biology rather than English at age 15 – despite an aptitude for the latter – I realized that science writing was a way to combine what I loved with what I was good at. From there I set out to gather as much freelancing experience as I could, spending 2 years developing scientific content for International Innovation, before completing an MSc in Science Communication. After gaining invaluable experience in supporting the communications efforts of CERN and IN-PART, I joined Texere – where I am focused on producing consistently engaging, cutting-edge and innovative content for our specialist audiences around the world.

More Articles by James Strachan

False

Advertisement

Recommended

False

Related Content

Managing Change in Devices for Patients
Drug Delivery
Managing Change in Devices for Patients

June 21, 2024

4 min read

We need to step away from assumptions on device interchangeability and find out what patients really want

Dosing to Circadian Rhythm
Drug Delivery
Dosing to Circadian Rhythm

December 1, 2014

0 min read

Could medicines be made more effective with better timing?

Connecting the Dots in Drug Delivery
Drug Delivery
Connecting the Dots in Drug Delivery

December 1, 2014

0 min read

The days of “low-hanging fruit” in drug discovery are a thing of the past...

Squid-Inspired Drug Delivery
Drug Delivery Dosage Forms Formulation
Squid-Inspired Drug Delivery

April 3, 2025

4 min read

Here’s how researchers took lessons from cephalopods to develop a new capsule that can deliver drugs, including insulin and siRNA, orally

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.